Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05412888 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of CoQ10 on the Endocrine Function of Skeletal Muscle

StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 4, 2023 (before its estimated July 31, 2023 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Jan 2023); last known: Not Yet Recruiting
  2. Start date: Sep 1, 2022 to Mar 1, 2023
    • Primary completion date: Mar 31, 2023 to Jul 31, 2023
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles. In the project, several research questions will be evaluated e.g. what is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in ischemic training, or what is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of ischemia preconditioning training etc.
Trial Details
NCT Number NCT05412888
Lead Sponsor Medical University of Gdansk
Conditions
(from sponsor)		 Ischemic Preconditioning, Coenzyme Q Deficiency, Exercise Training
Related terms Coenzyme Q10 Deficiency, Inflammation, Ischemia
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov